The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide

Immunology

Volumn 89, Issue 4, 1996, Pages 483-487

  Partidos, C D ^a,c   Pizza, M ^b   Rappuoli, R ^b   Steward, M W ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Immunobiol Res Institute of Siena   (Italy)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; IMMUNOLOGICAL ADJUVANT; MEASLES VACCINE; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ESCHERICHIA COLI; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; MEASLES VIRUS; MOUSE; MUCOSA; MUTANT; NONHUMAN; PRIORITY JOURNAL;

EID: 0029905760     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-790.x     Document Type: Article

References (25)

1. TAMURA S.I., ASAMURA H., ITO Y. et al. (1992) Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza haemagglutinin vaccine. Eur J Immunol 22, 477.
2. DALE J.B. & CHIANG E.C. (1995) Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections. J Infect Dis 171, 1038.
3. HATHAWAY L.J., PARTIDOS C.D., VOHRA P. & STEWARD M.W. (1995) Induction of systemic immune responses to measles virus synthetic peptides administered intranasally. Vaccine 13, 1495.
4. SPANGLER B.D. (1992) Structure and Function of Cholera Toxin and the Related Escherichia coli Heat-Labile Enterotoxin. Microbiol Rev 56, 622.
5. LYCKE N., TSUJI T. & HOLMGREN J. (1992) The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol 22, 2277.
6. PIZZA M., DOMENIGHINI M., HoL W. et al. (1994) Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol Microb 14 (1), 51.
7. PIZZA M., FONTANA M.R., GIULIANI M.M. et al. (1994) A genetically detoxified derivative of heat-labile Escherichia coli Enterotoxin induces neutralizing antibodies against the A subunit. J Exp Med 180, 2147.
8. DI TOMMASO A., SALETTI G., PIZZA M. et al. (1996) Induction of antigen specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun 64, 974.
9. CARBONE F.R. & BEVAN M.J. (1990) Class I restricted processing and presentation of exogenous associated antigen in vivo. J Exp Med 171, 377.
10. REDDY R., ZHOU F., NAIR S., HUANG L. & ROUSE B.T. (1992) In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J Immunol 148, 1585.
11. PARTIDOS C.D., VOHRA P. & STEWARD M.W. (1996) Priming of measles virus specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide. Virology 215, 107.
12. TAMURA S-I., YAMANAKA A., SHIMOHARA M. et al. (1994) Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 12, 419.
13. k restricted cytotoxic T lymphocyte epitopes in the measles virus nucleoprotein. Virology 203, 172.
14. RAGER ZISMAN B., EGAN J.E., KRESS Y. & BLOOM B.R. (1984) Isolation of cold sensitive mutants of measles virus from persistently infected murine neuroblastoma cells. J Virol 51, 845.
15. GOPAS J., ITZHAKY D., SEGEV Y. et al. (1992) Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells. Cancer Immunol Immunopathol 34, 313.
16. DERTZBAUGH M.T. & ELSON C.O. (1991) Cholera toxin as a mucosal adjuvant. In: Topics in Vaccine Adjuvant Research (eds R.R. Spriggs & W.C. Koff). CRS Press, Boca Raton, FL.
17. DOUCE G., TURCOTTE C., CROPLEY I. et al. (1995) Mutants of Escherichia coli heat labile toxin lacking ADP-ribosyltransferase activity act as nontoxic mucosal adjuvants. Proc Natl Acad Sci USA 92, 1644.
18. NASHAR T.O., AMIN T., MARCELLO A. & HIRST T.R. (1993) Current progress in the development of the B subunits of Cholera toxin and Escherichia coli heat-labile enterotoxin as carriers for the oral delivery of heterologous antigens and epitopes. Vaccine 11, 235.
19. GEURARSON S., TAMURA S-I., AIZAWA C. & KURATA T. (1992) Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit. Vaccine 10, 101.
20. CLARKE C.J., WILSON D.A., WILLIAMA N.A. & STOKES C.R. (1991) Mucosal priming of T lymphocyte responses to fed protein antigens using cholera toxin as an adjuvant. Immunology 72, 323.
21. LYCKE N. & STROBER W. (1989) Cholera toxin promotes B cell isotype differentiation. J Immunol 142, 3781.
22. BROMANDER A., HOLMGREN J. & LYCKE N. (1991) Cholera toxin stimulates IL-I production and enhances antigen presentation by macrophages in vitro. J Immunol 146, 2908.
23. LYCKE N., BROMANDER A.K., EKMAN L., KARLSSON U. & HOLMGREN J. (1989) Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J Immunol 142, 20.
24. BOWEN J.C., NAIR S.K., REDDY R. & ROUSE B.T. (1994) Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte resonses with non-replicating antigens. Immunology 81, 338.
25. PARTIDOS C.D., VOHRA P. & STEWARD M.W. (1996) Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides. Immunology 87, 179.